Gallbladder Cancer Market, By Treatment Type, By Cancer Type, By Distribution Channel, By Geography

PUBLISHED: November 10, 2023

PAGES: 150 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

The global gallbladder cancer market size is projected to reach US$ 100.1 million by 2030, from US$ 73.5 million in 2023, at a CAGR of 4.5% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 73.5 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	4.50%	2030 Value Projection:	US$ 100.1 Mn

Figure 1. Global Gallbladder Cancer Market Share (%), By Region, 2023

Gallbladder cancer is a relatively rare cancer that is most common in older women. It is often discovered at its late stage, when it is no longer possible to remove the gallbladder surgically. The gallbladder is a small, pear-shaped organ on the right side of the abdomen, just beneath the liver. The gallbladder stores bile, a digestive fluid produced by liver. Risk factors for gallbladder cancer include gallstones, gallbladder polyps, chronic gallbladder inflammation, and certain inherited conditions. Symptoms of gallbladder cancer may include abdominal pain, particularly in the upper right portion of the abdomen, abdominal bloating, fever, unintended weight loss, nausea, and yellowing of the skin and the whites of the eyes (jaundice).

Market Dynamics:

The global market for gallbladder cancer treatment is expected to witness significant growth in the coming years. The rising incidence of gallbladder cancer, primarily in developing countries, is a major driver for market growth. Additionally, advancements in diagnostic techniques and treatment modalities are enhancing the survival rates and quality of life for patients. For instance, according to the data published by the American Cancer Society in , about 12,220 new cases of gallbladder cancer : 5,750 in men and 6,470 in women in 2023.

Key features of the study:

This report provides an in-depth analysis of the global gallbladder cancer market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global gallbladder cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Eli Lilly and Company, Bristol-Myers Squibb, Roche, Pfizer, Novartis, Merck & Co., Inc., Sanofi, AstraZeneca, AbbVie, and Gilead Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global gallbladder cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gallbladder cancer market

Detailed Segmentation:

By Treatment Type
- Surgery
- Chemotherapy
- Radiation Therapy
- Immunotherapy
- Targeted Therapy
- Others
By Cancer Type
- Adenocarcinoma
- Squamous cell carcinoma
- Adenosquamous carcinoma
- Small cell carcinoma
- Undifferentiated carcinoma
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
By Region
- North America
- Europe
- APAC
- Latin America
- Middle East
- Africa
Top Players Operating in Gallbladder Cancer Market
- Eli Lilly and Company
- Bristol-Myers Squibb
- Roche
- Pfizer
- Novartis
- Merck & Co., Inc.
- Sanofi
- AstraZeneca
- AbbVie
- Gilead Sciences

Product Code: CMI6243

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Gallbladder Cancer Market, By Treatment Type
- Gallbladder Cancer Market, By Cancer Type
- Gallbladder Cancer Market, By Distribution Channel
- Gallbladder Cancer Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing prevalence of gallbladder cancer
- High cost burden of cancer therapies
- Development of targeted therapies
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Gallbladder Cancer Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Gallbladder Cancer Market, By Treatment Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Radiation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Gallbladder Cancer Market, By Cancer Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2018 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Adenocarcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Squamous cell carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Adenosquamous carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Small cell carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Gallbladder Cancer Market, By Distribution Channel, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2018 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Gallbladder Cancer Market, By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2018 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 - 2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2018-2030, (US$ Mn)
South Africa
North Africa
Central Africa

9. Competitive Landscape

Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Roche
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AbbVie
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Gilead Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views